FDA.reportPublic FDA data

{1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack

RxCUI
2626386
RxNorm name
{1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack
Display name
{1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack
Full name
{1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89abc31c-43e8-4809-9eb7-172cb31a86f1{1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack [GPCK] · sodium phenylbutyrate 2 GM Pack [PSN] · sodium phenylbutyrate 2 GM Pack [SY]34These highlights do not include all the information needed to use OLPRUVA TM safely and effectively. See full prescribing information for OLPRUVA. OLPRUVA (sodium phenylbutyrate) for oral suspension Initial U.S. Approval: 199620241218